drugset / Trial / NCT02101112

Bioavailability of Apixaban Crushed Tablet

NCT02101112

Phase 1 Completed 69 enrolled Bristol-Myers Squibb
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to determine whether the bioavailability of apixaban crushed tablets suspended in water or mixed with applesauce is similar to the bioavailability of apixaban whole tablets administered orally.

Timeline

Start
2014-03
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Apixaban Small molecule 10 mg Oral

Indications